期刊文献+

鼻咽癌64排CT表现与cerbB-2蛋白表达关系的研究 被引量:1

Study of CT Appearance with cerbB-2 Protein Expression in Nasopharyngeal Carcinoma
在线阅读 下载PDF
导出
摘要 目的研究cerbB-2蛋白表达与鼻咽癌64排CT表现的关系。方法经活检病理证实的鼻咽癌30例,均行64排螺旋CT扫描,收集CT征象,采用免疫组织化学方法检测cerbB-2蛋白表达情况,并分析CT征象与cerbB-2蛋白表达的相应关系。结果 cerbB-2蛋白阳性表达率与鼻咽癌肿块的多少及部位无关,差异无显著性意义(p>0.05);cerbB-2蛋白阳性表达率的程度与咽旁脂肪间隙是否消失、后鼻道、上颌窦有无侵及、以及颅底骨质是否破坏、颈部淋巴结有无转移有关,差异有显著性意义,(p<0.05)。结论 cerbB-2蛋白在鼻咽癌的发生、发展中起重要作用,其阳性表达程度与鼻咽癌的浸润深度和转移率有一定的相关性,因此cerbB-2蛋白表达率可作为评价鼻咽癌CT表现恶性程度及预后的指标。 Objective To study the relationship between the expression of cerbB-2 and 64-CT findings of nasopharyngeal carcinoma(NPC).Methods 30 patients of NPC were confirmed by biopsy with 64-CT scanning,then the relationship between the expressions of cerbB-2 and CT features was analyzed.Results The positive expression rates of cerbB-2 were difference non-significance in the sugar of the tumor and location.(p 0.05)The positive expression rates of cerbB-2 were significance in para pharyngeal space narrowing were showed and without,in posterior naris involved and without,in lower pharyngeal involved and without,inbone destruction of skull base and without,in lymph node metastasis in neck and without,(p 0.05).Conclusions cerbB-2 might play an important role in the pathegesis and development of nasopharyngeal carcinoma.cerbB-2 protein expression was correlated with invasive depth and prognosis metastasis.The positive expression rates of cerbB-2 could be served as indicator for predicting prognosis and malignancy of CT findings of nasopharyngeal carcinoma and prognosis.
出处 《中国医疗设备》 2011年第4期80-81,共2页 China Medical Devices
关键词 鼻咽癌 CERBB-2蛋白 免疫组化 CT征象 nasopharyngeal carcinoma cerbB-2 protein immunohistochemistry CT features
  • 相关文献

参考文献6

二级参考文献35

  • 1[1]Lin JC, Chen KY, Wang WY, et al. Detection of Epstein-Barr virus DNA the peripheral-blood cells of patients with nasopharyngeal carcinoma:relationship to diatant metastasis and survival [J].J Clin Oncol, 2001,19(10):2607-2615.
  • 2[2]Hsiao JR, Jin YT, Tsai ST. Detection of cell free Epstein-Barr virus DNA in sera from patient with nasopharyngeal carcinoma [J].Cancer,2002,94(3):723-729.
  • 3[3]Lo YM, Chan AT, Chan LY, et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulation Epstein-Barr virus DNA [J].Cancer Res, 2000,60(24):6878-6881.
  • 4[4]Ngan RK, Lau WH, Yip TT, et al. Remarkable application of serum EBV EBER-1 in monitoring response of nasopharyngeal cancer patients to salvage chemotherapy [J]. Ann N Y Acad Sci,2001,945(1):73-79.
  • 5[5]Yoshizaki T, Miwa H, Takeshita H, et al. Elavation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma [J]. J Cancer Res Clin Oncol, 2000,126(2):69-73.
  • 6[6]Dardari R, Khyatti M, Benider A, et al. Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma [J]. Iht J Cancer, 2000,86(1):71-75.
  • 7[7]Yoshizaki T,Miyamori H,Hasegawa K,et al.Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth [J]. Oncogene,2000,19(14):1764-1771.
  • 8[8]Fukuda M, Ikuta K, Yanagihara K, Tajima M, Kuratsune H, et al. Effect of transforming growth factor-betal on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines [J]. Virology,2001,288(1):109-118.
  • 9[9]Xu J, Menezes J, Prasad U, et al. Elevated serum levels of transforming growth factor beta1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients [J]. Int J Cancer, 1999,84(4):396-399.
  • 10[10]Cheng AJ, Chiu DT, See LC, et al. Poor prognosi in nasopharyngeal cancer patient with low glucose-6phosphate-dehydrogenase activity [J]. Jpn J Cancer Res, 2001,92(5):576-581.

共引文献35

同被引文献16

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部